Exelixis
EXEL
#2109
Rank
C$10.22 B
Marketcap
$35.84
Share price
-1.53%
Change (1 day)
23.67%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $66.80 CAD on 2000-07-26

Lowest end of day price: $1.75 CAD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$55.34-1.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
$78.17-1.08%๐Ÿ‡ซ๐Ÿ‡ท France
$158.93-0.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$67.02 0.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$457.62 0.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$222.66-0.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$39.90-0.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.02-0.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.35 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA